Virtual Reality Therapy for Inflammatory Bowel Disease

N/A

Recruiting

Led By Shirley Cohen-Mekelburg, MD, MS

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Patients with an uncontrolled cardiac condition such as an arrhythmia, coronary artery disease, or neurological/cerebrovascular disease

Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 week (semi-structured interview within 1 week of completion of the intervention)

Awards & highlights

No Placebo-Only Group

Summary

This trial is investigating the use of virtual reality therapy for patients with inflammatory bowel disease who are in the hospital. The goal is to see if this type of therapy is feasible and well-received for managing

Who is the study for?

This trial is for hospitalized patients with Inflammatory Bowel Disease (IBD) who are interested in trying a new pain treatment. The study will test if a Virtual Reality (VR)-directed therapy can help manage their pain while they're in the hospital.

What is being tested?

The intervention being studied is a VR-directed brain-gut behavioral therapy (BGBT). It's designed to see if using VR technology can be an effective way to treat pain for IBD patients during their hospital stay.

What are the potential side effects?

Since this trial involves non-invasive virtual reality therapy, there may not be typical medication side effects. However, participants might experience discomfort from wearing the VR headset or motion sickness.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have uncontrolled heart or brain conditions.

Select...

I have had seizures or episodes of losing awareness before.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 week (semi-structured interview within 1 week of completion of the intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 week (semi-structured interview within 1 week of completion of the intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week (semi-structured interview within 1 week of completion of the intervention) for reporting.